Evidence map›Paper›PMID 30655885›Full record

ArticleOncology letters2019

Systemic transduction of p16

Toru Shimazui, Kazuhiro Yoshikawa, Ryutaro Ishitsuka, Takahiro Kojima, Shuya Kandori, Takayuki Yoshino, Jun Miyazaki, Kazuhiko Uchida, Hiroyuki Nishiyama

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Toru ShimazuiDepartment of Urology, Ibaraki Clinical Education and Training Center, Faculty of Medicine, University of Tsukuba, Kasama, Ibaraki 309-1793, Japan.
Kazuhiro YoshikawaDivision of Research Creation and Biobank, Research Creation Support Center, Aichi Medical University, Nagakute, Aichi 480-1195, Japan.
Ryutaro IshitsukaDepartment of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Takahiro KojimaDepartment of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Shuya KandoriDepartment of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Takayuki YoshinoDepartment of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Jun MiyazakiDepartment of Urology, School of Medicine, International University of Health and Welfare, Ichikawa, Chiba 272-0827, Japan.
Kazuhiko UchidaDepartment of Molecular Biological Oncology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
Hiroyuki NishiyamaDepartment of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
University of Tsukuba · JPAichi Medical University · JPInternational University of Health and Welfare · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

p16

Indexed as

bladder cancerlung metastasisp16peptide transductionretinoblastoma

Identifiers

PMID30655885
PMCPMC6312983
OpenAlexW2899392943

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.